Delivery of aerosolized liposomal amikacin as a novel approach for the treatment of nontuberculous mycobacteria in an experimental model of pulmonary infection
about
Diagnosis and Treatment of Nontuberculous Mycobacterial Lung DiseaseDiagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease: Clinicians' PerspectivesDevelopment of Liposomal Ciprofloxacin to Treat Lung InfectionsInhaled Antibiotic Therapy in Chronic Respiratory Diseases.Mycobacterium avium Possesses Extracellular DNA that Contributes to Biofilm Formation, Structural Integrity, and Tolerance to AntibioticsResponse to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung DiseasePulmonary Deposition and Elimination of Liposomal Amikacin for Inhalation and Effect on Macrophage Function after Administration in RatsExamining the Effect of Residual Amikacin on Sputum Culture for Nontuberculous Mycobacteria.Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease.New antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug development.Destination of aminoglycoside antibiotics in the 'post-antibiotic era'.Nontuberculous Mycobacteria in Cystic Fibrosis.Amikacin Liposome Inhalation Suspension (ALIS) Penetrates Non-tuberculous Mycobacterial Biofilms and Enhances Amikacin Uptake Into Macrophages.Optimization and Lead Selection of Benzothiazole Amide Analogs Toward a Novel Antimycobacterial Agent
P2860
Q26748674-2861DD68-6FDA-43C6-80BC-5C7426B7BD20Q26749480-154CCF29-BFE5-44EC-B581-9D4A652A006EQ26764772-6E4DAB65-C01A-41B6-9640-A75002411EADQ33755342-5AA0D54F-93FD-4FF1-B980-F3BEA81D2D95Q35641482-C68441C1-93FE-4DFC-8FBB-91A3D81154D4Q35859886-637CB089-0FD2-4BA8-9821-5EECE8D59D46Q37358621-360D7F20-2512-4162-8FE1-6CAAA6CEA563Q40160676-2ED9DD1C-16C1-4F37-91F3-B848365A5149Q40504302-64F7238C-4F7E-4CEC-BFF9-89965A87E6ECQ47594312-FAE526DC-E97B-4C3A-A368-AA580C7C2A4DQ50079038-4496A73F-754D-461F-8ADB-7DC59B741721Q52768051-AAFF6465-48D3-42F7-9D83-2523B89AAF12Q55057435-D24A1D63-3B6E-4DAA-99FC-07C90C4C1AA5Q57191759-537C802D-622B-4919-AEB4-5ACD4200D630
P2860
Delivery of aerosolized liposomal amikacin as a novel approach for the treatment of nontuberculous mycobacteria in an experimental model of pulmonary infection
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Delivery of aerosolized liposo ...... l model of pulmonary infection
@ast
Delivery of aerosolized liposo ...... l model of pulmonary infection
@en
Delivery of aerosolized liposo ...... l model of pulmonary infection
@nl
type
label
Delivery of aerosolized liposo ...... l model of pulmonary infection
@ast
Delivery of aerosolized liposo ...... l model of pulmonary infection
@en
Delivery of aerosolized liposo ...... l model of pulmonary infection
@nl
prefLabel
Delivery of aerosolized liposo ...... l model of pulmonary infection
@ast
Delivery of aerosolized liposo ...... l model of pulmonary infection
@en
Delivery of aerosolized liposo ...... l model of pulmonary infection
@nl
P2093
P2860
P1433
P1476
Delivery of aerosolized liposo ...... l model of pulmonary infection
@en
P2093
Luiz E Bermudez
Mary E Neville
Renu Gupta
Sasha J Rose
P2860
P304
P356
10.1371/JOURNAL.PONE.0108703
P407
P577
2014-09-29T00:00:00Z